Free Trial

Jushi (OTCMKTS:JUSHF) Stock Price Up 0.8% - Still a Buy?

Jushi logo with Medical background

Key Points

  • Jushi Holdings Inc. (OTCMKTS:JUSHF) shares rose by 0.8% to trade at $0.75, with an increased trading volume of 1,321,850 shares, significantly higher than its average volume of 718,409 shares.
  • The company reported a quarterly revenue of $65.05 million, which surpassed analyst estimates of $64.67 million, while the earnings per share (EPS) met expectations at ($0.06).
  • Jushi is a vertically integrated cannabis company that produces a diverse range of cannabis products, including flower, extracts, and edibles, under various brand names like The Bank and Nira+ Medicinals.
  • MarketBeat previews top five stocks to own in October.

Jushi Holdings Inc. (OTCMKTS:JUSHF - Get Free Report)'s stock price shot up 0.8% during trading on Thursday . The stock traded as high as $0.85 and last traded at $0.75. 1,321,850 shares traded hands during mid-day trading, an increase of 84% from the average session volume of 718,409 shares. The stock had previously closed at $0.75.

Jushi Stock Performance

The stock has a fifty day moving average price of $0.51 and a two-hundred day moving average price of $0.38. The firm has a market capitalization of $149.20 million, a P/E ratio of -2.62 and a beta of -0.98.

Jushi (OTCMKTS:JUSHF - Get Free Report) last issued its quarterly earnings data on Tuesday, August 5th. The company reported ($0.06) earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of ($0.06). The business had revenue of $65.05 million during the quarter, compared to the consensus estimate of $64.67 million. As a group, research analysts anticipate that Jushi Holdings Inc. will post -0.23 earnings per share for the current fiscal year.

Jushi Company Profile

(Get Free Report)

Jushi Holdings Inc, a vertically integrated cannabis company, engages in the cultivation, processing, retail, and distribution of cannabis for medical and adult-use markets. The company offers flower, extracts, concentrates, edibles, oil, pre-rolls, tinctures, capsules, softgels, cannabis-infused gummies and ultra-premium chocolate, and topicals products, as well as vaporization devices and cartridges under The Bank, The Lab, Nira+ Medicinals, Sèchè, Tasteology, and Hijinks brands.

Further Reading

Should You Invest $1,000 in Jushi Right Now?

Before you consider Jushi, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Jushi wasn't on the list.

While Jushi currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Stocks to Own: Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Hot Stocks to Buy Now: September’s Top Picks With Major Momentum
$15 Billion for Cybersecurity: The Government’s Next Big Push
Tesla’s Future Unleashed: Elon’s Robotics Move Changes Everything

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines